$17.8bn
$XXX.Xm
86,615
398
$X.Xbn
The blood and organ bank industry, reliant on donations, experienced slower revenue growth and volatility amid the pandemic. Blood donations decreased and led to shortages and procedures demanding industry products declined due to quarantine mandates and fear of hospitals. Organ donations remained steady, but supply-demand equilibrium was disturbed due to the increased number of patients waiting for transplants. With corporate blood donations remaining slow as remote work persists, but with school and college donations picking up, the industry grew at a CAGR of 1.7% through 2023 and is expected to reach $17.8 billion in 2024.
Industry revenue has grown at a CAGR of 1.7 % over the past five years, to reach an estimated $17.8bn in 2024.
Market size is projected to grow over the next five years.
Company | Market Share (%)
2024 | Revenue ($m)
2024 | Profit ($m)
2024 | Profit Margin (%)
2024 |
---|---|---|---|---|
Psychemedics Corporation | 18.2 | 0.7 | 4.1 |
To view the market share and analysis for all 1 top companies in this industry, view purchase options.
Industry revenue is measured across several distinct product and services lines, including Red blood cell collection, processing, and distribution services, Blood plasma collection, processing, and distribution services and Organ bank services . Red blood cell collection, processing, and distribution services is the largest segment of the Blood & Organ Banks in the US.
Blood-related services are the lifeblood of the industry
The Blood and Organ Banks industry includes companies that primarily collect, store and distribute human blood, blood products and human organs.
Purchase this report to view all 1 major companies in this industry.
NAICS 62199 - Blood & Organ Banks in the US
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Blood and organ banks have limited strategic power. Unable to effect a change in the need for services and facing volatile donations, companies must weather supply and demand...
Learn about an industry's products and services, markets and trends in international trade.
An aging population with Medicare coverage will benefit from all services. An aging population with Medicare coverage will support growth and performance in blood, organ and ...
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Populous and older states are a draw. Three of the most populated states also hold a large share of the adult population over 65 years, explaining the large percentage of est...
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Concentration occurs where the healthcare facilities locate. Locations with an extensive healthcare infrastructure draw providers since the firm can benefit from economies of...
Learn about the performance of the top companies in the industry.
You can bank on the American Red Cross. A nonprofit company with a significant market share in blood and organ bank services, it delivers aid and support worldwide in its hum...
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Service providers have little control over the volatility of revenue. External forces (disasters, epidemics, cultural attitudes, government assistance, insurance funding) inf...
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Labor cost is a two-edged sword. While the industry benefits from volunteer labor, volunteers are in greater supply in populated areas where other healthcare facilities bid u...
Including values and annual change:
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Unlock comprehensive answers and precise data upon purchase. View purchase options.
The market size of the Blood & Organ Banks in the US industry in United States is $17.8bn in 2024.
There are 398 businesses in the Blood & Organ Banks in the US industry in United States, which has grown at a CAGR of 4.8 % between 2019 and 2024.
The market size of the Blood & Organ Banks in the US industry in United States has been growing at a CAGR of 1.7 % between 2019 and 2024.
Over the next five years, the Blood & Organ Banks in the US industry in United States is expected to grow.
The biggest company operating in the Blood & Organ Banks market in United States is Psychemedics Corporation
Red blood cell collection, processing, and distribution services and Blood plasma collection, processing, and distribution services are part of the Blood & Organ Banks in the US industry.
The company holding the most market share in United States is Psychemedics Corporation.
The level of competition is moderate and steady in the Blood & Organ Banks in the US industry in United States.